A High Decipher Genomic Risk Score Is Associated with Major Pathological Progression in Patients Undergoing Active Surveillance for Prostate Cancer

Key Points

• Pathological progression is significantly associated with a high genomic risk score in prostate cancer patients.
• Patients with high genomic risk scores showed a notable increase in disease progression rates over time.
• Analysis across various clinical settings demonstrated the impact of genomic risk scores on patient outcomes.
• The findings highlight the need for integrating genomic risk assessment in active surveillance for better patient management.